These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 27430152

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Nutlin-3 overcomes arsenic trioxide resistance and tumor metastasis mediated by mutant p53 in Hepatocellular Carcinoma.
    Zheng T, Yin D, Lu Z, Wang J, Li Y, Chen X, Liang Y, Song X, Qi S, Sun B, Xie C, Meng X, Pan S, Liu J, Jiang H, Liu L.
    Mol Cancer; 2014 May 31; 13():133. PubMed ID: 24884809
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Type IIA topoisomerase (TOP2A) triggers epithelial-mesenchymal transition and facilitates HCC progression by regulating Snail expression.
    Dong Y, Sun X, Zhang K, He X, Zhang Q, Song H, Xu M, Lu H, Ren R.
    Bioengineered; 2021 Dec 31; 12(2):12967-12979. PubMed ID: 34939898
    [Abstract] [Full Text] [Related]

  • 6. GP73 promotes epithelial-mesenchymal transition and invasion partly by activating TGF-β1/Smad2 signaling in hepatocellular carcinoma.
    Yang Y, Liu Q, Li Z, Zhang R, Jia C, Yang Z, Zhao H, Ya S, Mao R, Ailijiang T, Bao Y, Zhang H.
    Carcinogenesis; 2018 Jul 03; 39(7):900-910. PubMed ID: 29365054
    [Abstract] [Full Text] [Related]

  • 7. Synergistic effect of nutlin-3 combined with aspirin in hepatocellular carcinoma HepG2 cells through activation of Bcl-2/Bax signaling pathway.
    Miao R, Xu X, Wang Z, Liu S, Qu K, Chen W, Liu C.
    Mol Med Rep; 2018 Mar 03; 17(3):3735-3743. PubMed ID: 29286113
    [Abstract] [Full Text] [Related]

  • 8. Long non-coding RNA NRON is downregulated in HCC and suppresses tumour cell proliferation and metastasis.
    Yao Z, Xiong Z, Li R, Liang H, Jia C, Deng M.
    Biomed Pharmacother; 2018 Aug 03; 104():102-109. PubMed ID: 29772429
    [Abstract] [Full Text] [Related]

  • 9. Cx32 reverses epithelial-mesenchymal transition in doxorubicin-resistant hepatocellular carcinoma.
    Yu M, Han G, Qi B, Wu X.
    Oncol Rep; 2017 Apr 03; 37(4):2121-2128. PubMed ID: 28260043
    [Abstract] [Full Text] [Related]

  • 10. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD, Wei JC, Qu K, Wang ZX, Wu QF, Tai MH, Liu HC, Zhang RY, Liu C.
    World J Gastroenterol; 2015 Jan 07; 21(1):196-213. PubMed ID: 25574092
    [Abstract] [Full Text] [Related]

  • 11. Scorpion inhibits epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Yan YQ, Xie J, Wang JF, Shi ZF, Zhang X, Du YP, Zhao XC.
    Exp Biol Med (Maywood); 2018 Apr 07; 243(7):645-654. PubMed ID: 29486578
    [Abstract] [Full Text] [Related]

  • 12. Upregulation of microRNA-140-3p inhibits epithelial-mesenchymal transition, invasion, and metastasis of hepatocellular carcinoma through inactivation of the MAPK signaling pathway by targeting GRN.
    Zhang QY, Men CJ, Ding XW.
    J Cell Biochem; 2019 Sep 07; 120(9):14885-14898. PubMed ID: 31044454
    [Abstract] [Full Text] [Related]

  • 13. The role of CD29-ILK-Akt signaling-mediated epithelial-mesenchymal transition of liver epithelial cells and chemoresistance and radioresistance in hepatocellular carcinoma cells.
    Jiang X, Wang J, Zhang K, Tang S, Ren C, Chen Y.
    Med Oncol; 2015 May 07; 32(5):141. PubMed ID: 25805567
    [Abstract] [Full Text] [Related]

  • 14. CCR7 preservation via histone deacetylase inhibition promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells.
    Yang L, Chang Y, Cao P.
    Exp Cell Res; 2018 Oct 01; 371(1):231-237. PubMed ID: 30107147
    [Abstract] [Full Text] [Related]

  • 15. Berberine Suppresses EMT in Liver and Gastric Carcinoma Cells through Combination with TGFβR Regulating TGF-β/Smad Pathway.
    Du H, Gu J, Peng Q, Wang X, Liu L, Shu X, He Q, Tan Y.
    Oxid Med Cell Longev; 2021 Oct 01; 2021():2337818. PubMed ID: 34712379
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma.
    Wang W, Lin H, Zhou L, Zhu Q, Gao S, Xie H, Liu Z, Xu Z, Wei J, Huang X, Zheng S.
    Eur J Surg Oncol; 2014 Nov 01; 40(11):1586-94. PubMed ID: 24290372
    [Abstract] [Full Text] [Related]

  • 17. RANKL promotes migration and invasion of hepatocellular carcinoma cells via NF-κB-mediated epithelial-mesenchymal transition.
    Song FN, Duan M, Liu LZ, Wang ZC, Shi JY, Yang LX, Zhou J, Fan J, Gao Q, Wang XY.
    PLoS One; 2014 Nov 01; 9(9):e108507. PubMed ID: 25268581
    [Abstract] [Full Text] [Related]

  • 18. Epithelial-mesenchymal transition plays a critical role in drug resistance of hepatocellular carcinoma cells to oxaliplatin.
    Ma JL, Zeng S, Zhang Y, Deng GL, Shen H.
    Tumour Biol; 2016 May 01; 37(5):6177-84. PubMed ID: 26614432
    [Abstract] [Full Text] [Related]

  • 19. NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer.
    Liu S, Sun J, Cai B, Xi X, Yang L, Zhang Z, Feng Y, Sun Y.
    Tumour Biol; 2016 Jul 01; 37(7):9671-80. PubMed ID: 26801672
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.